# High-Throughput Screening (HTS) Platform for Discovery of Medications to Treat Alcohol Use Disorder (R43/R44 Clinical Trials Not Allowed)

Source: https://welltoldgrants.com/grants/rfa-aa-24-001-high-throughput-screening-hts-platform-for-discovery-of/  
Official notice: https://www.grants.gov/search-results-detail/351606

> National Institutes of Health offered grants to small businesses. Applications closed on April 9, 2024.

| Field | Value |
|---|---|
| Opportunity number | RFA-AA-24-001 |
| Agency | National Institutes of Health |
| Status | Forecast |
| Deadline | April 9, 2024 |
| Award ceiling | not stated |
| Award floor | not stated |
| Expected awards | not stated |
| Total funding | not stated |
| Cost sharing | not required |
| Assistance Listings | 93.273 |

## Who can apply

- Small businesses

Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.

## What the grant funds

This Notice of Funding Opportunity (NOFO) supports Small Business Innovation Research (SBIR) applications from small business concerns (SBCs) in the development of a new, or optimization of an existing, in vivo and/or in vitro high-throughput screening (HTS) platform for use in identifying potential compounds for treating alcohol use disorder (AUD). Potential screening platform assays will consist of small vertebrate (excluding rodent) and invertebrate model organisms and human cell- and tissue-based models. The platform assays must be sensitive to different concentrations of alcohol, as well as treatment effects, such that any changes to the model can be measured accurately and reproducibly and can be used as outcome variables.

## Questions people ask

### Is RFA-AA-24-001 still open?

No. It closed on April 9, 2024.

### Who can apply for High-Throughput Screening (HTS) Platform for Discovery of Medications to Treat Alcohol Use Disorder (R43/R44 Clinical Trials Not Allowed)?

National Institutes of Health accepted applications from small businesses. The notice adds further conditions, so read its eligibility section.

### What is the deadline for High-Throughput Screening (HTS) Platform for Discovery of Medications to Treat Alcohol Use Disorder (R43/R44 Clinical Trials Not Allowed)?

Closed April 9, 2024. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### Who has been funded under RFA-AA-24-001?

NIH RePORTER lists 1 project funded under RFA-AA-24-001 in fiscal 2025, at 1 institution.

### Who has won Alcohol Research Programs grants before?

The largest recipients over five fiscal years were Yale Univ, University of North Carolina at Chapel Hill, Trustees of Indiana University. The program made 2,255 awards worth $2.2 billion in that time.